Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

The recruitment status of this study is unknown because the information has not been verified recently.

Verified August 2004 by National Taiwan University Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

National Taiwan University Hospital

ClinicalTrials.gov Identifier:

NCT00173316

First received: September 12, 2005

Last updated: NA

Last verified: August 2004

History: No changes posted

Purpose

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Condition
Oral Cancer

Study Type:	Observational
Study Design:	Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Retrospective
Official Title:	The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

Resource links provided by NLM:

MedlinePlus related topics: Cancer Oral Cancer

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment:	80
Study Start Date:	August 2004
Estimated Study Completion Date:	June 2005

Detailed Description:

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Eligibility

Ages Eligible for Study:	18 Years to 85 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

oral cancer and oral precancer specimens

Exclusion Criteria:

other diseases

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00173316

Contacts

Contact: Chun-Pin Chiang, DMSc

886-2-23123456 ext 6855

cpchiang@ha.mc.ntu.edu.tw

Locations

Taiwan
National Taiwan university	Recruiting
Taipei, Taiwan, 100
Principal Investigator: Chun-Pin Chiang, DMSc

Sponsors and Collaborators

National Taiwan University Hospital

Investigators

Principal Investigator:

Chun-Pin Chiang, DMSc

National Taiwan University

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00173316 History of Changes
Other Study ID Numbers:	9461700614
Study First Received:	September 12, 2005
Last Updated:	September 12, 2005
Health Authority:	Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:

vascular endothelial growth factor-C
VEGF-CR
lymphangiogenesis
host inflammatory responses

oral carcinogenesis
oral cancers
oral premalignant lesions

Additional relevant MeSH terms:

Mouth Neoplasms
Lip Neoplasms
Precancerous Conditions
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms
Mouth Diseases
Stomatognathic Diseases

Lip Diseases
Mitogens
Endothelial Growth Factors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Growth Substances
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on June 17, 2013

To Top